Pre- and post-initiation chemoprevention activity of 2-alkyl/aryl selenazolidine-4(R)-carboxylic acids against tobacco-derived nitrosamine (NNK)-induced lung tumors in the A/J mouse

Chemico-Biological Interactions

Volumn 168, Issue 3, 2007, Pages 211-220

  Franklin, Michael R ^a   Moos, Philip J ^a   El Sayed, Wael M ^a   Aboul Fadl, Tarek ^a   Roberts, Jeanette C ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cancer chemoprevention; Lung cancer; Selenazolidine; Selenium; Tobacco derived nitrosamine

Indexed keywords

2 (2' HYDROXYPHENYL)SELENAZOLIDINE 4 CARBOXYLIC ACID; 2 BUTYLSELENAZOLIDINE 4 CARBOXYLIC ACID; 2 CYCLOHEXYLSELENAZOLIDINE 4 CARBOXYLIC ACID; 2 OXOSELENAZOLIDINE 4 CARBOXYLIC ACID; 2 PHENYLSELENAZOLIDINE 4 CARBOXYLIC ACID; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CARBOXYLIC ACID DERIVATIVE; SELENAZOLIDINE DERIVATIVE; SELENIUM DERIVATIVE; SELENOCYSTINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE EXPRESSION PROFILING; GENOME; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TUMOR VOLUME;

ANIMALS; CARCINOGENS; DIETARY SUPPLEMENTS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MICE; MOLECULAR STRUCTURE; NEOPLASMS, EXPERIMENTAL; NITROSAMINES; ORGANOSELENIUM COMPOUNDS; PROLINE; TOBACCO;

MUS; NICOTIANA TABACUM;

EID: 34250881542     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.04.012     Document Type: Article

References (45)

1. Wynder E.L. The past, present, and future of the prevention of lung cancer. Cancer Epidemiol. Biomark. Prev. 7 (1998) 735-748
2. Hoffmann D., Hoffmann I., and El-Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14 (2001) 767-790
3. Hecht S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 3 (2002) 461-469
4. Hoffmann D., Djordjevic M.V., Fan J., Zang E., Glynn T., and Connolly G.N. Five leading U.S. commercial brands of moist snuff in 1994; assessment of carcinogenic N-nitrosamines. J. Natl. Cancer Inst. 87 (1995) 1862-1869
5. Murrah V.A., Gilchrist E.P., and Moyer M.P. Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. Oral Surg. Oral Med. Oral Pathol. 75 (1993) 323-332
6. Brunnemann K.D., Prokopczyk B., Kjordjevic M.V., and Hoffmann D. Formation and analysis of tobacco-specific N-nitrosamines. Crit. Rev. Toxicol. 26 (1996) 121-137
7. Adams J.D., Lee S.J., Vinchkoski N., Castonguay A., and Hoffmann D. On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking. Cancer Lett. 17 (1983) 339-346
8. Chhabra S.K., Souliotis V.L., Kyrtopoulos S.A., and Anderson L.M. Nitrosamines, alcohol, and gastrointestinal tract cancer: recent epidemiology and experimentation. In Vivo 10 (1996) 265-284
9. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11 (1998) 559-603
10. Peterson L.A., Thomson N.M., Crankshaw D.L., Donaldson E.E., and Kenney P.J. Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs: implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis. Cancer Res. 61 (2001) 5757-5763
11. Fischer S., Spiegelhalder B., Eisenbarth J., and Preussmann R. Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis 11 (1990) 723-730
12. Shimkin M.B., and Stoner G.D. Lung tumors in mice: application to carcinogenesis bioassay. Adv. Cancer Res. 21 (1975) 1-58
13. Malkinson A.M. Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res. 52 (1992) 2670s-2676s
14. Ip C. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res. 41 (1981) 4386-4390
15. Ip C., and Sinha D. Anticarcinogenic effect of selenium in rats treated with dimethylbenz[a]anthracene and fed different levels and types of fat. Carcinogenesis 2 (1981) 435-438
16. Medina D., Lane H.W., and Tracey C.M. Selenium and mouse mammary tumorigenesis: an investigation of possible mechanisms. Cancer Res. 43 (1983) 2460s-2464s
17. Ip C., and White G. Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions. Carcinogenesis 8 (1987) 1763-1766
18. Ip C., Hayes C., Budnick R.M., and Ganther H.E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res. 51 (1991) 595-600
19. Nayini J., El-Bayoumy K., Sugie S., Cohen L.A., and Reddy B.S. Chemoprevention of experimental mammary carcinogenesis by the synthetic organoselenium compound, benzylselenocyanate, in rats. Carcinogenesis 10 (1989) 509-512
20. Li L., Xie Y., El-Sayed W.M., Szakacs J.G., Franklin M.R., and Roberts J.C. Chemopreventive activity of selenocysteine prodrugs against tobacco-derived nitrosamine (NNK) induced lung tumors in the A/J mouse. J. Biochem. Mol. Toxicol. 19 (2005) 396-405
21. El-Bayoumy K., Upadhyaya P., Desai D.H., Amin S., and Hecht S.S. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis 14 (1993) 1111-1113
22. Lane H.W., Teer P., Dukes J., Johnson J., and White M.T. The effect of four chemical forms of selenium on mammary tumor incidence in BALB/c female mice treated with 7-12-dimethylbenz[a]anthracene. Cancer Lett. 50 (1990) 39-44
23. Prokopczyk B., Amin S., Desai D.H., Kurtzke C., Upadhyaya P., and El-Bayoumy K. Effects of 1,4-phenylenebis(methylene)selenocyanate and selenomethionine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung. Carcinogenesis 18 (1997) 1855-1857
24. Nagasawa H.T., Goon D.J.W., Zera R.T., and Yuzon D.L. Prodrugs of l-cysteine as liver-protective agents. 2(R,S)-methylthiazolidine-4(R)-carboxylic acid, a latent cysteine. J. Med. Chem. 25 (1982) 489-491
25. Swede H., Dong Y., Reid M., Marshall J., and Ip C. Cell cycle arrest biomarkers in human lung cancer cells after treatment with selenium in culture. Cancer Epidemiol. Biomark. Prev. 12 (2003) 1248-1252
26. El-Bayoumy K., Das A., Narayanan B., Narayanan N., Fiala E.S., Desai D., Rao C.V., Amin S., and Sinha R. Molecular targets of the chemopreventive agent 1,4-phenylenebis(methylene) selenocyanate in human non small cell lung cancer. Carcinogenesis 27 (2006) 1369-1376
27. Xie Y., Short M.D., Cassidy P.B., and Roberts J.C. Selenazolidines as novel organoselenium delivery agents. Bioorg. Med. Chem. Lett. 11 (2001) 2911-2915
28. Short M.D., Xie Y., Li L., Cassidy P.B., and Roberts J.C. Characteristics of selenazolidine prodrugs of selenocysteine: toxicity and glutathione peroxidase induction in V79 cells. J. Med. Chem. 46 (2003) 3308-3313
29. Hecht S.S., Morse M.A., Amin S., Stoner G.D., Jordan K.G., Choi C.-I., and Chung F.-L. Rapid single-dose model for lung tumor induction in A/J Mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis 10 (1989) 1901-1904
30. Hecht S.S., Morse M.A., Eklind K.I., and Chung F.L. A/J mouse lung tumorigenesis by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by arylalkyl isothiocyanates. Exp. Lung Res. 17 (1991) 501-511
31. Malkinson A.M., and Deer D.S. Major effect on susceptibility to urethane-induced pulmonary adenoma by a single gene in BALB/cBy mice. J. Natl. Cancer Inst. 70 (1983) 931-936
32. Pavlidis P., and Noble W.S. Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol. 2 (2001) RESEARCH0042
33. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5116-5121
34. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., and Chinnaiyan A.M. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6 (2004) 1-6
35. Chen G., Wang H., Gharib T.G., Huang C.C., Thomas D.G., Shedden K.A., Kuick R., Taylor J.M., Taylor J.M., Kardia S.L., Misek D.E., Giordano T.J., Iannettoni M.D., Orringer M.B., Hanash S.M., and Beer D.G. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol. Cell. Proteomics 2 (2003) 107-116
36. Shamberger R.J. Relationship of selenium to cancer. I. Inhibitory effect of selenium on carcinogenesis. J. Natl. Cancer Inst. 44 (1970) 931-936
37. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S., Wang G.Q., Yang C.S., Zheng S.F., Gail M., and Li G.Y. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85 (1993) 1483-1492
38. Taylor E.W., Nadimpalli R.G., and Ramanathan C.S. Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol. Trace Elem. Res. 56 (1997) 63-91
39. Mark S.D., Qiao Y.L., Dawsey S.M., Wu Y.P., Katki H., Gunter E.W., Fraumeni Jr. J.F., Blot W.J., Dong Z.W., and Taylor P.R. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J. Natl. Cancer Inst. 92 (2000) 1753-1763
40. Shamberger R.J., and Willis C.E. Selenium distribution and human cancer mortality. CRC Crit. Rev. Clin. Lab. Sci. 2 (1971) 211-221
41. Clark L.C., Cantor K.P., and Allaway W.H. Selenium in forage crops and cancer mortality in U.S. counties. Arch. Environ. Health 46 (1991) 37-42
42. Clark L.C., Combs Jr. G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher Jr. J.L., Park H.K., Sanders Jr. B.B., Smith C.L., Taylor J.R., and Nutritional Prevention of Cancer Study Group. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 276 (1996) 1957-1963
43. Combs Jr. G.F., and Gray W.P. Chemopreventive agents: Selenium. Pharmacol. Ther. 79 (1998) 179-192
44. Combs Jr. G.F. Current evidence and research needs to support a health claim for selenium and cancer prevention. J. Nutr. 135 (2005) 343-347
45. Prokopczyk B., Cox J.E., Upadhyaya P., Amin S., Desai D., Hoffmann D., and El-Bayoumy K. Effects of dietary 1,4 phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats. Carcinogenesis 17 (1996) 749-753